Sort
64,565 grants matching “drug discovery”
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)
$729,722Michael Benatar · University Of Miami School Of Medicine · U01 · FY2019 · NS
High Throughput Drug Screening Robot
$729,690Kevin G Rice · University Of Iowa · S10 · FY2011 · RR
CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity
$729,420William E. Evans · St. Jude Children'S Research Hospital · P50 · FY2018 · GM
Compact, Neon/Cryocooled NMR Magnets Assembled from Superconducting YBCO Annuli
$729,403Yukikazu Na Iwasa · Massachusetts Institute Of Technology · R01 · FY2009 · EB
Small molecule enhancers of tumor immunity targeting the LPA5 GPCR
$729,283Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2025 · CA
High-throughput Functional Analysis of Autism Risk Genes
$729,220Ellen J Hoffman · Yale University · R01 · FY2025 · MH
Genetic Susceptibility To Carcinogens
$729,214Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Scalable platform for optimizing human cardiac tissue engineering via optical pacing and on-demand oxygenation
$728,876Emilia Entcheva · George Washington University · R01 · FY2019 · HL
HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I
$728,832Matt Surman · Albany Molecular Research, Inc. · N01 · FY2022 · DA
A genomewide study of lung cancer in never smokers
$728,823Olga Gorlova · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Pharmacogenomics of Bronchodilator Response in Minority Children with Asthma
$728,802Esteban Gonzalez Burchard · University Of California, San Francisco · R01 · FY2015 · HL
Peroxynitrate neutralizing agents for stroke therapy
$728,754Inotek Pharmaceuticals Corporation · R44 · FY2002 · NS
Nonlipogenic ABCA1 inducers for ADRD
$728,720Gregory R J Thatcher · University Of Arizona · U01 · FY2025 · AG
Investigating the role of Alzheimer's disease familial mutations in neuromuscular physiology
$728,632James J Hickman · University Of Central Florida · R01 · FY2025 · AG
Small molecules for perturbing iron homeostasis in bacterial biofilms
$728,617Mario Rivera · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2023 · AI
Calmodulin and Regulation of Cardiac Ryanodine Receptor and CaMKII
$728,602Donald M Bers · University Of California At Davis · R01 · FY2025 · HL
Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD
$728,550Pamela Anne Maher · Virogenics, Inc. · R42 · FY2017 · AI
Development of Population Level Serotyping Technology and Antibody Profiling for Infectious Pathogens with focus on Influenza and SARS-CoV-2
$728,518Eric Okerberg · Encodia, Inc. · R44 · FY2020 · CA
AN OPEN RESOURCE TO ADVANCE COMPUTER-AIDED DRUG DESIGN
$728,423Victoria Ann Feher · University Of California, San Diego · U01 · FY2014 · GM
Lead Optimization of DHODH Inhibitors for Malaria
$728,403Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2020 · AI
RNAi-dependent epimutation roles in antimicrobial drug resistance and pathogenesis
$728,332Joseph Heitman · Duke University · R01 · FY2025 · AI
BIODIVERSITY CONSERVATION & DRUG DISCOVERY IN MADAGASCAR
$728,311David G Kingston · Virginia Polytechnic Inst And St Univ · U01 · FY2007 · TW
Senior Leadership
$727,872Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2014 · CA
Senior Leadership
$727,872Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2015 · CA
Lead Optimization of DHODH Inhibitors for Malaria
$727,804Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2019 · AI